Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugs

Technology appraisal guidance
Reference number: TA225
Published: 22 June 2011

Letter from the Department of Health confirming NICE can consider the Patient Access Scheme

Letter from the Department of Health confirming NICE can consider the Patient Access Scheme

Letter from the Department of Health confirming NICE can consider the Patient Access Scheme
13 May 2011
(40.26 Kb 11 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 12 May 2011